BioMarin Pharmaceutical | BMRN

Aktienkurs
54.49
Täglich Wechseln
0.39 0.72%
Monatlich
-1.70%
Jährlich
-7.09%
Q2 Prognose
53.04

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-04-29 FY2026Q1 PM 0.74 1.13
2026-02-23 FY2025Q4 PM 0.46 0.77 0.92
2025-10-27 FY2025Q3 PM 0.12 0.86 0.91
2025-08-04 FY2025Q2 PM 1.44 0.84 0.96
2025-05-01 FY2025Q1 PM 1.13 0.65 0.71



Preis Chg Tag Jahr Datum
Acadia Pharmaceuticals 22.04 0.79 3.72% 53.27% 2026-04-17
Agios Pharmaceuticals 35.18 0.26 0.74% 28.68% 2026-04-17
Alnylam Pharmaceuticals 307.92 -12.21 -3.81% 32.30% 2026-04-17
Amgen 355.19 5.80 1.66% 29.78% 2026-04-17
Bayer 41.10 0.41 1.01% 91.30% 2026-04-17
Biogen 176.21 0.19 0.11% 51.27% 2026-04-17
BioMarin Pharmaceutical 54.49 0.39 0.72% -7.09% 2026-04-17
Gilead Sciences 137.88 -0.67 -0.48% 31.31% 2026-04-17
Incyte 97.59 2.27 2.38% 71.81% 2026-04-17
Insmed 144.16 1.37 0.96% 107.39% 2026-04-17

Preis Tag Jahr Datum
USND 24451 348.33 1.45% 54.06% 2026-04-17